---
title: "enGene Therapeutics Inc. Stock 12‑Month Price Target Cut to $3.43, Implies 102% Upside"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296007261.md"
description: "enGene Therapeutics Inc.'s average 12-month price target was cut to $3.43 from $3.50 by seven analysts, with forecasts ranging from $2 to $5. Based on the Aug. 14 close, this implies a 102% upside. The consensus rating remains 'Hold' among 10 covering analysts, comprising four buys, five holds, and one sell."
datetime: "2026-08-15T20:20:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296007261.md)
  - [en](https://longbridge.com/en/news/296007261.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296007261.md)
generator: "portal-rs"
---

# enGene Therapeutics Inc. Stock 12‑Month Price Target Cut to $3.43, Implies 102% Upside

-   According to estimates from 7 analysts, enGene Therapeutics Inc. stock's average price target has fallen from $3.5 to $3.43, with forecasts ranging from $2 to $5 per share
-   Based on the Aug. 14 closing price, the updated target implies approximately 102% potential upside
-   Consensus rating remains at “Hold” across 10 covering analysts, with 4 Buys, 5 Holds and 1 Sells

Explore more price target data and ratings for enGene Therapeutics Inc. on the , and track all previous and future analyst recommendations for enGene Therapeutics Inc. in the dedicated News Flow.

**Disclaimer**

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.

### Related Stocks

- [ENGN.US](https://longbridge.com/en/quote/ENGN.US.md)
- [ENGNW.US](https://longbridge.com/en/quote/ENGNW.US.md)

## Related News & Research

- [Tribe Property Technologies Inc. reports Q2 results](https://longbridge.com/en/news/296953133.md)
- [LSL Pharma Group Inc. reports Q2 results](https://longbridge.com/en/news/296953883.md)
- [Vise Technologies Inc. Takes $743,000 Position in Halozyme Therapeutics, Inc. $HALO](https://longbridge.com/en/news/296763264.md)
- [EarthLabs Inc. GAAP EPS of $0.01](https://longbridge.com/en/news/296951906.md)
- [Vyome Holdings, Inc. reports Q2 results](https://longbridge.com/en/news/296950745.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**